New cell models and assays in cardiac safety profiling

• DARPO B, ALMGREN O, BERGSTRAND R et al.: Tolerance and effects of almokalant, a new selective Ik blocking agent, on ventricular repolarization and on sino-atrial and atrioventricular nodal function in the heart: a study in healthy, male volunteers utilizing transesophageal atrial stimulation. J. Cardiovasc. Pharmacol. (1995) 25(5):681-690.
   PubMed Web of Science ®Google Scholar
• KJEKSHUS J, BATHEN J, ORNING OM, STORSTEIN L: A double-blind, crossover comparison of flecainide acetate and disopyramide phosphate in the treatment of ventricular premature complexes. Am. J. Cardiol. (1984) 53(5):B72-B78.
   PubMed Web of Science ®Google Scholar
• DARPO B, VALLIN H, ALMGREN O et al.: Selective Ik blocker almokalant exhibits class III-specific effects on the repolarization and refractoriness of the human heart: a study of healthy volunteers using right ventricular monophasic action potential recordings. J. Cardiovasc. Pharmacol. (1995) 26(4):530-540.
   PubMed Web of Science ®Google Scholar
• BEDFORD TA, ROWBOTHAM DJ: Cisapride. Drug interactions of clinical significance. Drug Saf. (1996) 15(3):167-175.
   PubMed Web of Science ®Google Scholar
• GUNASEKARAN TS, DUBROW I: Cisapride-induced long QT interval: what is the role of ranitidine? J. Pediatr. (1997) 130(4):679-680.
   PubMed Web of Science ®Google Scholar
• LEWIN MB, BRYANT RM, FENRICH AL, GRIFKA RG: Cisapride-induced long QT interval. J. Pediatr. (1996) 128(2):279-281.
   PubMed Web of Science ®Google Scholar
• KULKARNI SM, AGARWAL HK, SHAIKH AA: Torsade de pointes complicating treatment with astemizol. Indian Heart J. (1994) 46(3):179-180.
   PubMedGoogle Scholar
• BISCHOFF U, SCHMIDT C, NETZER R, PONGS O: Effects of fluoroquinolones on HERG currents. Eur. J. Pharmacol. (2000) 406(3):341-343.
   PubMed Web of Science ®Google Scholar
• PATMORE L, FRASER S, MAIR D, TEMPLETON A: Effects of sparfloxacin, grepafloxacin, moxifloxacin, and ciprofloxacin on cardiac action potential duration. Eur. J. Pharmacol. (2000) 406(3):449-452.
   PubMed Web of Science ®Google Scholar
• KOH KK, RIM MS, YOON J, KIM SS: Torsade de pointes induced by terfenadine in a patient with long QT syndrome. J. Electrocardiol. (1994) 27(4):343-346.
   PubMed Web of Science ®Google Scholar
• RODEN DM: Torsade de pointes. Clin. Cardiol. (1993) 16(9):683-686.
   PubMed Web of Science ®Google Scholar
• FARHANGI V, SANSONE RA: QTc prolongation due to propranolol overdose. Int. J. Psychiatry Med. (2003) 33(2):201-202.
   PubMed Web of Science ®Google Scholar
• HADDAD PM, ANDERSON IM: Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs (2002) 62(11):1649-1671.
   PubMed Web of Science ®Google Scholar
• PACHER P, KECSKEMETI V: Cardiovascular side effects of new antidepressants and antipsychotics: new drugs, old concerns? Curr. Pharm. Des. (2004) 10(20):2463-2475.
   PubMed Web of Science ®Google Scholar
• CHEN C, FOLCH A: A high-performance elastomeric patch clamp chip. Lab Chip (2006) 6(10):1338-1345.
   PubMed Web of Science ®Google Scholar
• DUBIN AE, NASSER N, ROHRBACHER J et al.: Identifying modulators of hERG channel activity using the PatchXpress planar patch clamp. J. Biomol. Screen. (2005) 10(2):168-181.
   PubMed Web of Science ®Google Scholar
• WANG X, LI M: Automated electrophysiology: high throughput of art. Assay Drug Dev. Technol. (2003) 1(5):695-708.
   PubMed Web of Science ®Google Scholar
• FERTIG N, BLICK RH, BEHRENDS JC: Whole cell patch clamp recording performed on a planar glass chip. Biophys. J. (2002) 82(6):3056-3062.
   PubMed Web of Science ®Google Scholar
• FISH JM, DI DIEGO JM, NESTERENKO V, ANTZELEVITCH C: Epicardial activation of left ventricular wall prolongs QT interval and transmural dispersion of repolarization: implications for biventricular pacing. Circulation (2004) 109(17):2136-2142.
   PubMed Web of Science ®Google Scholar
• DEMOLIS JL, FUNCK-BRENTANO C, ROPERS J et al.: Influence of dofetilide on QT-interval duration and dispersion at various heart rates during exercise in humans. Circulation (1996) 94(7):1592-1599.
   PubMed Web of Science ®Google Scholar
• FINLAYSON K, TURNBULL L, JANUARY CT, SHARKEY J, KELLY JS: [3H]dofetilide binding to HERG transfected membranes: a potential high throughput preclinical screen. Eur. J. Pharmacol. (2001) 430(1):147-148.
   PubMed Web of Science ®Google Scholar
• CHIU PJ, MARCOE KF, BOUNDS SE et al.: Validation of a [3H]astemizole binding assay in HEK293 cells expressing HERG K+ channels. J. Pharmacol. Sci. (2004) 95(3):311-319.
   PubMed Web of Science ®Google Scholar
• MARTIN RL, MCDERMOTT JS, SALMEN HJ et al.: The utility of hERG and repolarization assays in evaluating delayed cardiac repolarization: influence of multi-channel block. J. Cardiovasc. Pharmacol. (2004) 43(3):369-379.
   PubMed Web of Science ®Google Scholar
• MURPHY SM, PALMER M, POOLE MF et al.: Evaluation of functional and binding assays in cells expressing either recombinant or endogenous hERG channel. J. Pharmacol. Toxicol. Methods (2006) 54(1):42-55.
   PubMedGoogle Scholar
• DORN A, HERMANN F, EBNETH A et al.: Evaluation of a high-throughput fluorescence assay method for HERG potassium channel inhibition. J. Biomol. Screen. (2005) 10(4):339-347.
   PubMed Web of Science ®Google Scholar
• NYGREN A, BACZKO I, GILES WR: Measurements of electrophysiological effects of components of acute ischemia in Langendorff-perfused rat hearts using voltage-sensitive dye mapping. J. Cardiovasc. Electrophysiol. (2006) 17(Suppl. 1):S113-S123.
   PubMed Web of Science ®Google Scholar
• ZHANG Y, HAN H, WANG J et al.: Impairment of human ether-a-go-go-related gene (HERG) K+ channel function by hypoglycemia and hyperglycemia. Similar phenotypes but different mechanisms. J. Biol. Chem. (2003) 278(12):10417-10426.
   PubMed Web of Science ®Google Scholar
• LEPPLE-WIENHUES A, FERLINZ K, SEEGER A, SCHAFER A: Flip the tip: an automated, high quality, cost-effective patch clamp screen. Receptors Channels (2003) 9(1):13-17.
   PubMedGoogle Scholar
• MATHES C: QPatch: the past, present and future of automated patch clamp. Expert Opin. Ther. Targets (2006) 10(2):319-327.
   PubMed Web of Science ®Google Scholar
• FINKEL A, WITTEL A, YANG N et al.: Population patch clamp improves data consistency and success rates in the measurement of ionic currents. J. Biomol. Screen. (2006) 11(5):488-496.
   PubMed Web of Science ®Google Scholar
• JOHN VH, DALE TJ, HOLLANDS EC et al.: Novel 384-well population patch clamp electrophysiology assays for Ca2+-activated K+ channels. J. Biomol. Screen. (2006) 12(1):50-60.
   Google Scholar
• NEHER E, SAKMANN B, STEINBACH JH: The extracellular patch clamp: a method for resolving currents through individual open channels in biological membranes. Pflugers Arch. (1978) 375(2):219-228.
   PubMed Web of Science ®Google Scholar
• SAKMANN B, NEHER E: Patch clamp techniques for studying ionic channels in excitable membranes. Ann. Rev. Physiol. (1984) 46:455-472.
   PubMed Web of Science ®Google Scholar
• THOMAS D, WENDT-NORDAHL G, ROCKL K et al.: High-affinity blockade of human ether-a-go-go-related gene human cardiac potassium channels by the novel antiarrhythmic drug BRL-32872. J. Pharmacol. Exp. Ther. (2001) 297(2):753-761.
   PubMed Web of Science ®Google Scholar
• ZHOU Z, GONG Q, YE B et al.: Properties of HERG channels stably expressed in HEK 293 cells studied at physiological temperature. Biophys. J. (1998) 74(1):230-241.
   PubMed Web of Science ®Google Scholar
• WOOSLEY RL, SALE M: QT interval: a measure of drug action. Am. J. Cardiol. (1993) 72(6):B36-B43.
   PubMed Web of Science ®Google Scholar
• YUN CH, OKERHOLM RA, GUENGERICH FP: Oxidation of the antihistaminic drug terfenadine in human liver microsomes. Role of cytochrome P-450 3A(4) in N-dealkylation and C-hydroxylation. Drug Metabol. Dispos. Biol. Fate Chem. (1993) 21(3):403-409.
   PubMed Web of Science ®Google Scholar
• SORKIN EM, HEEL RC: Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1985) 29(1):34-56.
   PubMed Web of Science ®Google Scholar
• ROTI EC, MYERS CD, AYERS RA et al.: Interaction with GM130 during HERG ion channel trafficking. Disruption by type 2 congenital long QT syndrome mutations. Human ether-a-go-go-related gene. J. Biol. Chem. (2002) 277(49):47779-47785.
   PubMed Web of Science ®Google Scholar
• BINAH O, GILAT E, RUBINSTEIN I, OPPENHEIMER E: Electrophysiological effects of a novel antiarrhythmic drug, EO-122, on guinea pig ventricular muscle and isolated myocytes. J. Cardiovasc. Pharmacol. (1987) 10(3):301-308.
   PubMed Web of Science ®Google Scholar
• LU HR, VLAMINCKX E, VAN AMMEL K, DE CLERCK F: Drug-induced long QT in isolated rabbit Purkinje fibers: importance of action potential duration, triangulation and early afterdepolarizations. Eur. J. Pharmacol. (2002) 452(2):183-192.
   PubMed Web of Science ®Google Scholar
• HONDEGHEM LM: Thorough QT/QTc not so thorough: removes torsadogenic predictors from the T-wave, incriminates safe drugs, and misses profibrillatory drugs. J. Cardiovasc. Electrophysiol. (2006) 17(3):337-340.
   PubMed Web of Science ®Google Scholar
• LUX RL, FULLER MS, MACLEOD RS et al.: QT interval dispersion: dispersion of ventricular repolarization or dispersion of QT interval? J. Electrocardiol. (1998) 30(Suppl.):176-180.
   PubMed Web of Science ®Google Scholar
• PINNEY SP, KOLLER BS, FRANZ MR, WOOSLEY RL: Terfenadine increases the QT interval in isolated guinea pig heart. J. Cardiovasc. Pharmacol. (1995) 25(1):30-34.
   PubMed Web of Science ®Google Scholar
• HASKILL JS, MOORE MA: Two dimensional cell separation: comparison of embryonic and adult haemopoietic stem cells. Nature (1970) 226(5248):853-854.
   PubMed Web of Science ®Google Scholar
• GABBIANELLI M, SARGIACOMO M, PELOSI E et al.: “Pure” human hematopoietic progenitors: permissive action of basic fibroblast growth factor. Science (1990) 249(4976):1561-1564.
   PubMed Web of Science ®Google Scholar
• PITTENGER MF, MACKAY AM, BECK SC et al.: Multilineage potential of adult human mesenchymal stem cells. Science (1999) 284(5411):143-147.
   PubMed Web of Science ®Google Scholar
• GEARHART J: New potential for human embryonic stem cells. Science (1998) 282(5391):1061-1062.
   PubMed Web of Science ®Google Scholar
• AKANO T, KODAMA H, HONJO T: In vitro development of primitive and definitive erythrocytes from different precursors. Science (1996) 272(5262):722-724.
   PubMed Web of Science ®Google Scholar
• IGELMUND P, FLEISCHMANN BK, FISCHER IR et al.: Action potential propagation failures in long-term recordings from embryonic stem cell-derived cardiomyocytes in tissue culture. Pflugers Arch. (1999) 437(5):669-679.
   PubMed Web of Science ®Google Scholar
• SAUER H, RAHIMI G, HESCHELER J, WARTENBERG M: Effects of electrical fields on cardiomyocyte differentiation of embryonic stem cells. J. Cell Biochem. (1999) 75(4):710-723.
   PubMed Web of Science ®Google Scholar
• WOBUS AM, KLEPPISCH T, MALTSEV V, HESCHELER J: Cardiomyocyte-like cells differentiated in vitro from embryonic carcinoma cells P19 are characterized by functional expression of adrenoceptors and Ca2+ channels. In Vitro Cell Dev. Biol. Anim. (1994) 30A(7):425-434.
   PubMed Web of Science ®Google Scholar
• BIN Z, SHENG LG, GANG ZC et al.: Efficient cardiomyocyte differentiation of embryonic stem cells by bone morphogenetic protein-2 combined with visceral endoderm-like cells. Cell Biol. Int. (2006) 30(10):769-776.
   PubMed Web of Science ®Google Scholar
• PASSIER R, OOSTWAARD DW, SNAPPER J et al.: Increased cardiomyocyte differentiation from human embryonic stem cells in serum-free cultures. Stem Cells (2005) 23(6):772-780.
   PubMed Web of Science ®Google Scholar
• ROHWEDEL J, MALTSEV V, BOBER E et al.: Muscle cell differentiation of embryonic stem cells reflects myogenesis in vivo: developmentally regulated expression of myogenic determination genes and functional expression of ionic currents. Dev. Biol. (1994) 164(1):87-101.
   PubMed Web of Science ®Google Scholar
• BANACH K, HALBACH MD, HU P, HESCHELER J, EGERT U: Development of electrical activity in cardiac myocyte aggregates derived from mouse embryonic stem cells. Am. J. Physiol. (2003) 284(6):H2114-H2123.
   Web of Science ®Google Scholar
• HALBACH M, EGERT U, HESCHELER J, BANACH K: Estimation of action potential changes from field potential recordings in multicellular mouse cardiac myocyte cultures. Cell Physiol. Biochem. (2003) 13(5):271-284.
   PubMed Web of Science ®Google Scholar
• HESCHELER J, HALBACH M, EGERT U et al.: Determination of electrical properties of ES cell-derived cardiomyocytes using MEAs. J. Electrocardiol. (2004) 37(Suppl.):110-116.
   PubMed Web of Science ®Google Scholar
• DE PONTI F, POLUZZI E, CAVALLI A, RECANATINI M, MONTANARO N: Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview. Drug Saf. (2002) 25(4):263-286.
   PubMed Web of Science ®Google Scholar
• REDFERN WS, CARLSSON L, DAVIS AS et al.: Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovas. Res. (2003) 58(1):32-45.
   PubMed Web of Science ®Google Scholar
• HALBACH M, PILLEKAMP F, BROCKMEIER K et al.: Ventricular slices of adult mouse hearts–a new multicellular in vitro model for electrophysiological studies. Cell Physiol. Biochem. (2006) 18(1-3):1-8.
   PubMed Web of Science ®Google Scholar
• PILLEKAMP F, REPPEL M, DINKELACKER V et al.: Establishment and characterization of a mouse embryonic heart slice preparation. Cell Physiol. Biochem. (2005) 16(1-3):127-132.
   PubMed Web of Science ®Google Scholar
• ANTZELEVITCH C: Cardiac repolarization. The long and short of it. Europace (2005) 7(Suppl. 2):3-9.
   PubMedGoogle Scholar
• YAO JA, JIANG M, FAN JS, ZHOU YY, TSENG GN: Heterogeneous changes in K currents in rat ventricles three days after myocardial infarction. Cardiovas. Res. (1999) 44(1):132-145.
   PubMed Web of Science ®Google Scholar
• ANTZELEVITCH C, SHIMIZU W, YAN GX, SICOURI S: Cellular basis for QT dispersion. J. Electrocardiol. (1998) 30(Suppl.):168-175.
   PubMed Web of Science ®Google Scholar
• MEYER T, LEISGEN C, GONSER B, GUNTHER E: QT-screen: high-throughput cardiac safety pharmacology by extracellular electrophysiology on primary cardiac myocytes. Assay Drug Dev. Technol. (2004) 2(5):507-514.
   PubMed Web of Science ®Google Scholar
• STETT A, EGERT U, GUENTHER E et al.: Biological application of microelectrode arrays in drug discovery and basic research. Anal. Bioanal. Chem. (2003) 377(3):486-495.
   PubMed Web of Science ®Google Scholar
• AKAR FG, YAN GX, ANTZELEVITCH C, ROSENBAUM DS: Unique topographical distribution of M cells underlies reentrant mechanism of torsade de pointes in the long-QT syndrome. Circulation (2002) 105(10):1247-1253.
   PubMed Web of Science ®Google Scholar
• EL-SHERIF N: Early afterdepolarizations and arrhythmogenesis. Experimental and clinical aspects. Arch. Mal. Coeur Vaiss (1991) 84(2):227-234.
   PubMedGoogle Scholar
• SHAH RR: Drug-induced QT interval prolongation: regulatory perspectives and drug development. Ann. Med. (2004) 36(Suppl 1):47-52.
   PubMed Web of Science ®Google Scholar
• VISWANATHAN PC, RUDY Y: Pause induced early afterdepolarizations in the long QT syndrome: a simulation study. Cardiovas. Res. (1999) 42(2):530-542.
   PubMed Web of Science ®Google Scholar
• LEE K, PARK JY, RYU PD, KWON LS, KIM HY: IKr channel blockers: novel antiarrhythmic agents. Curr. Med. Chem. Cardiovasc. Hematol. Agents (2003) 1(3):203-223.
   PubMedGoogle Scholar
• ECKARDT L, HAVERKAMP W, BORGGREFE M, BREITHARDT G: Experimental models of torsade de pointes. Cardiovas. Res. (1998) 39(1):178-193.
   PubMed Web of Science ®Google Scholar
• SHAH RR: Drug-induced QT dispersion: does it predict the risk of torsade de pointes? J. Electrocardiol. (2005) 38(1):10-18.
   PubMed Web of Science ®Google Scholar
• TURGEON J, DALEAU P, BENNETT PB et al.: Block of IKs, the slow component of the delayed rectifier K+ current, by the diuretic agent indapamide in guinea pig myocytes. Circ. Res. (1994) 75(5):879-886.
   PubMed Web of Science ®Google Scholar
• VISWANATHAN PC, SHAW RM, RUDY Y: Effects of IKr and IKs heterogeneity on action potential duration and its rate dependence: a simulation study. Circulation (1999) 99(18):2466-2474.
   PubMed Web of Science ®Google Scholar
• VOLDERS PG, STENGL M, VAN OPSTAL JM et al.: Probing the contribution of IKs to canine ventricular repolarization: key role for β-adrenergic receptor stimulation. Circulation (2003) 107(21):2753-2760.
   PubMed Web of Science ®Google Scholar
• FICKER E, DENNIS A, KURYSHEV Y, WIBLE BA, BROWN AM: HERG channel trafficking. Novartis Found. Symp. (2005) 266:57-69; discussion 70-54, 95-59.
   PubMedGoogle Scholar
• WIBLE BA, HAWRYLUK P, FICKER E et al.: HERG-Lite: a novel comprehensive high-throughput screen for drug-induced hERG risk. J. Pharmacol. Toxicol. Methods (2005) 52(1):136-145.
   PubMedGoogle Scholar
• LAWRENCE CL, POLLARD CE, HAMMOND TG, VALENTIN JP: Nonclinical proarrhythmia models: predicting Torsades de Pointes. J. Pharmacol. Toxicol. Methods (2005) 52(1):46-59.
   PubMedGoogle Scholar

Website

• http://www.fenichel.net/pages/Professional/subpages/QT/Tables/pbydrug.htm
   Google Scholar